<DOC>
	<DOCNO>NCT01475435</DOCNO>
	<brief_summary>Abstract Diabetes mellitus periodontal disease chronic inflammatory disorder major impact health well million individual worldwide . Periodontal disease among common disease human , therefore , presence periodontal disease play role overall systemic health , public health impact may substantial . An important factor involve progression periodontal disease production Reactive Oxygen Species ( ROS ) . The imbalance oxidative stress induce ROS concentration ( activity ) antioxidant may result tissue damage . The ROS induce activity lipid peroxidation-Tbars , myeloperoxidase ( MPO ) , peroxidase arginase , whose mechanism reflect severity periodontal disease may offer basis patient specific diagnostic test periodontitis could therapeutic significance . The aim study investigate quantitatively level oxidative stress marker ( Myeloperoxidase , Peroxidase , Lipid Peroxidation Arginase ) saliva gingival crevicular fluid ( GCF ) diabetes type 2 subject generalize chronic periodontitis periodontally healthy individual , systematically healthy individual generalize chronic periodontitis periodontally healthy individual , periodontal treatment . Unstimulated whole saliva collect 5 min well GCF 25 diabetes type 2 generalize chronic periodontitis , 25 diabetes type 2 periodontally healthy individual control , 25 systematically healthy individual generalize chronic periodontitis 25 periodontally healthy individual treatment . The following clinical parameter evaluate : probe pocket depth , probe attachment level , plaque index gingival index . The activity stress marker saliva GFC analyze spectrophotometry . Adequate statistical analysis carry p-value set p &lt; 0.05 .</brief_summary>
	<brief_title>Oxidative Stress Markers Evaluation Before After Periodontal Treatment Diabetics Type 2 Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients type 2 diabetes chronic periodontitis ( 30 % site involve , AAP , 1999 ) Patients type 2 diabetes periodontally healthy ( AAP , 1999 ) Patients systemically healthy chronic periodontitis ( 30 % site involve ) Patients systemically periodontally healthy Patients least 15 natural teeth ( exclude 3rd molar ) . At least 30 % site probe pocket depth ( PD ) &gt; 5 mm maximum 60 % site PS &lt; 7 mm Clinical attachment level ( CAL ) &gt; 4 mm Visible plaque bleed probe ( BOP ) Patients type 2 diabetes bear disease least five year show blood percentage glycated hemoglobin 6.5 % 8 % ( UKPDS 1998 ) baseline Exclusion Criteria Individuals periodontal pocket deeper 7 mm Patients systemic disease ( except diabetes type 2 ) Patients use medication anticoagulant , contraceptive antidepressant past 6 month Patients use antibiotic antiinflammatory drug last 3 month study Smoking Pregnancy Patients receive periodontal treatment last six month start study .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>